Chains & Business

New bill aims to support generic, biosimilar drug competitionThe CREATES Act came about because some pharmaceutical manufacturers are misusing the REMS program to prevent generic drug development.
Insurers restricting high-risk opioid users to select pharmaciesAs the opioid epidemic continues to get worse, some health insurers are blocking patients identified as “high risk” from getting multiple opioid prescriptions filled at various pharmacies by restricting where they can fill prescriptions.
How one pharmacy survived the Baltimore riotsPharmacist Maisha McCoy will never forget those tense days in late April 2015, when rioting and looting were widespread throughout Baltimore.